What is immunotherapy? You will know after reading this

Immunotherapy for recurrent miscarriage first appeared in 1981. After decades of clinical trials, the success rate of immunotherapy for recurrent miscarriage is now between 55% and 100%. The key to successful treatment is to strictly grasp the details. Immunotherapy for recurrent miscarriage involves multiple system engineering and requires a good hospital and operation team.

Nowadays, many women suffer from multiple miscarriages due to various reasons, and then suffer from habitual miscarriage. Most of the habitual miscarriages are caused by multiple miscarriages. If you know the cause of habitual miscarriage, it is generally recoverable. If the cause of habitual miscarriage is unknown, doctors generally recommend immunotherapy. What is immunotherapy? Next, let's take a closer look at the immunotherapy of habitual miscarriage.
Development of immunotherapy <br/>Active immunotherapy was co-founded by doctors Beer and Taylor in 1981. After decades of improvement and development, modern science and technology have raised the success rate of active immunotherapy for primary habitual abortion to 55%-100%. This treatment effect is already amazing and has received a lot of attention in the medical community. Immunotherapy is mainly based on immunology. If you want to have a successful pregnancy, you must prevent harmful immune responses. Studies have shown that autoimmune diseases that are mainly cellular immunity will be alleviated to a certain extent during pregnancy, but humoral immunity will further deteriorate. Therefore, during normal pregnancy, the mother's humoral immunity is the main factor.
The key to the success of immunotherapy <br/>There are many keys to the success of immunotherapy, and only when they are achieved at the same time will immunotherapy be successful. The lack of any one of them may affect the effect of immunotherapy, or even fail. The first is to strictly select cases, and then conduct strict special examinations on selected patients to determine the treatment plan, followed by the preparation of immunogens and biological safety tests, and then real-time observation of treatment effects, strengthening post-pregnancy immunotherapy, and finally auxiliary treatment. It can be said that these points complement each other and are linked together. The more perfect the connection of each step, the higher the chance of success of immunotherapy.
Immunotherapy for habitual miscarriage requires high standards from doctors because it involves complicated processes and requires experienced doctors.